Cancer Family
Embryonal Neoplasm
CI-CAN-00000013Explore in graph →
Non-malignant285 active trials7 approved drugs73 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000013Explore in graph →
Clinical trials
1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05592743 | Vorasidenib Expanded Access Program | approved for marketing | — | — | ServierINDUSTRY | 0 | Jul 24, 2026 | clinicaltrials |
| NCT00730444 | Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma | approved for marketing | — | — | GE HealthcareINDUSTRY | 1 | Nov 9, 2009 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 24, 2026source: clinicaltrials